Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2COVID-19 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hypogonadism 1Head and Neck Neoplasms 1HIV Infections 1Death 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

Specimen Handling 5Biopsy 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 3sodium-iodide symporter 2ruxolitinib 2duvelisib 2cemiplimab 2X-Rays 2Vincristine 2Prednisone 2Photons 2Immunoglobulin G 2Etoposide 2Doxorubicin 2Disulfides 2prednylidene 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Stem Cell Transplantation 1Standard of Care 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Nivolumab 1Melphalan 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Practice Guidelines as Topic × 30 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡